Suppression of Amphiregulin/Epidermal Growth Factor Receptor Signals Contributes to the Protective Effects of Quercetin in Cirrhotic Rats ,
- 1 July 2011
- journal article
- Published by Elsevier in The Journal of Nutrition
- Vol. 141 (7) , 1299-1305
Abstract
The hepatic wound-healing response to chronic noxious stimuli may lead to liver fibrosis, a key feature of the preneoplastic cirrhotic liver. FibrogeKeywords
This publication has 44 references indexed in Scilit:
- Modulation of the cannabinoid receptors by andrographolide attenuates hepatic apoptosis following bile duct ligation in rats with fibrosisApoptosis, 2010
- Amphiregulin attenuates bleomycin-induced pneumopathy in miceAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2010
- Cloning of the Human GLI2 PromoterJournal of Biological Chemistry, 2009
- Epidermal Growth Factor Receptor Signaling Synergizes with Hedgehog/GLI in Oncogenic Transformation via Activation of the MEK/ERK/JUN PathwayCancer Research, 2009
- The epidermal growth factor receptor ligand amphiregulin participates in the development of mouse liver fibrosis†Hepatology, 2008
- EGFR Signaling Is Required for TGF-β1–Mediated COX-2 Induction in Human Bronchial Epithelial CellsAmerican Journal of Respiratory Cell and Molecular Biology, 2007
- The EGF receptor is required for efficient liver regenerationProceedings of the National Academy of Sciences, 2007
- The Gli code: an information nexus regulating cell fate, stemness and cancerTrends in Cell Biology, 2007
- Metalloprotease-dependent amphiregulin release mediates tumor necrosis factor-α-induced IL-8 secretion in the human airway epithelial cell line NCI-H292Life Sciences, 2006
- Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis†Hepatology, 2005